AI assistant
ABBOTT LABORATORIES — Director's Dealing 2005
Apr 26, 2005
29777_dirs_2005-04-26_f2030b34-5bb3-4e0d-b9d0-1fd0d3d98a81.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2005-04-22
Reporting Person: REYNOLDS W ANN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-04-22 | Common shares without par value | A | 1889 | — | Acquired | 34875 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 1625 | Indirect |
| Common shares without par value | 693 | Indirect |
Footnotes
F1: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid in Abbott common shares, on a one-to-one basis, on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).
F2: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions were exempt from Section 16 under Rule 16a-11.
F3: The reporting person disclaims beneficial ownership of all securities held by her husband.